CHICAGO, Aug. 23, 2024 /PRNewswire/ — The global Ablation Technology Market is valued at an estimated USD 6.11 billion in 2024 and is projected to reach USD 9.62 billion by 2029 at a CAGR of 9.5% during the forecast period. The ablation technology market is driven by expanding access to healthcare, a preference for minimally invasive treatments, and the application of ablation procedures in new fields. Key factors include rising public awareness campaigns, increasing global healthcare expenditure, and supportive reimbursement policies. Emerging markets like India and China present significant growth opportunities due to expanding private healthcare sectors and growing patient populations. However, challenges include rigorous regulatory frameworks and therapeutic complications such as adverse effects from cryogenic gases. The market is segmented by technology, with radiofrequency ablation leading in 2023 due to its safety and efficacy. Consumables dominate by product type, driven by increased oncological surgeries and the need for single-use devices. Cardiovascular disease treatment holds the largest application share, while hospitals, surgical centers, and ablation centers are the primary end users. North America, particularly the US, is expected to remain the largest market due to its technological advancements and supportive healthcare infrastructure. Major players include Johnson & Johnson, Medtronic, Boston Scientific, Abbott, and Atricure.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=791
Browse in-depth TOC on “Ablation Technology Market”
226 – Tables
64 – Figures
290 – Pages
Johnson & Johnson: Innovator in Ablation Technology
Johnson & Johnson (US) is a prominent player in the ablation technology market through its subsidiaries, Ethicon Inc. and Biosense Webster, Inc. The company specializes in pulsed field ablation platforms and therapeutic catheters. To expand its portfolio, Johnson & Johnson acquired Laminar, Inc. (US), enhancing its capabilities in this field. Committed to advancing patient outcomes, the company invests significantly in research and development. With 89 manufacturing facilities, primarily in the US, Johnson & Johnson offers its products globally through direct presence and various distribution channels.
Medtronic Plc: Global Leader in Ablation Solutions
Medtronic Plc (US) is a major force in the ablation technology market, operating in over 150 countries across North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. The company provides cardiac ablation solutions through its cardiac rhythm & heart failure segment and offers gastrointestinal and endoscopy ablation systems under its Medical Surgical Portfolio. Additionally, Medtronic’s neuromodulation division supplies tumor ablation systems. Its global presence and extensive reach support its robust position in the market.
Boston Scientific Corporation: Strategic Innovator in Ablation Technology
Boston Scientific Corporation (US) is a key player in the ablation technology market, focusing on innovation and strategic acquisitions. The company acquired Lumenis LTD (Israel), known for its laser systems, and strengthened its electrophysiology portfolio by purchasing Farapulse, Inc. (US) and Relievant Medsystems, Inc. (US). With 15 manufacturing facilities worldwide, including eight in the US and Puerto Rico, and distribution centers across major regions, Boston Scientific continues to drive growth through strategic investments and global presence.
Abbott: Expanding Its Ablation Technology Portfolio
Abbott (US) provides ablation devices and catheters under its electrophysiology subsegment. Operating through 291 international and 100 domestic subsidiaries, including Abbott GmbH & Co., KG (Germany) and Abbott Cardiovascular, Inc. (US), Abbott offers a wide range of products globally. The company’s acquisition of Cardiovascular Systems Inc. (US) has enhanced its portfolio with alternative solutions for vascular disease treatment. Abbott’s global reach and strategic acquisitions underline its commitment to expanding its ablation technology offerings.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=791
Product Segment: Consumables Dominate Ablation Technology Market
The ablation technology market is divided into two primary segments: ablation systems and consumables. In 2023, the consumables segment held the largest market share. This dominance is driven by a growing patient population, increasing awareness of early detection, and advancements in consumable technologies. These factors have significantly boosted demand for consumables in the market.
Application Segment: Cardiovascular Disease Treatment Leads Market
The market is segmented by application into cardiovascular disease treatment, cancer treatment, orthopedic treatment, cosmetic/aesthetic treatment, urological treatment, gynecological treatment, pain management, ophthalmological treatment, and other applications. In 2023, cardiovascular disease treatment was the largest segment. The segment’s growth is fueled by a rise in global cardiovascular disease cases, new product launches and approvals for cardiac ablation solutions, and supportive reimbursement policies.
End User Segment: Hospitals and Surgical Centers Lead Market
End users of ablation technology include hospitals, surgical centers, ablation centers, ambulatory surgical centers, medical spas, aesthetic clinics, dermatology clinics, and other facilities. In 2023, hospitals, surgical centers, and ablation centers held the largest market share. The increase in hospital numbers and partnerships with insurance companies allows for investment in advanced ablation technologies, leading to broader adoption and improved patient care.
Regional Insights: North America Holds Largest Market Share
The ablation technology market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2023, North America accounted for the largest market share, followed by Europe and Asia Pacific. Asia Pacific is anticipated to exhibit the highest growth rate from 2024 to 2029. North America’s market dominance is attributed to the presence of major players, high incidence of relevant diseases, and robust research activities.
For more information, inquire now! Inquire Now
Related Reports:
Electrosurgery Market
Tumor Ablation Market
Neuromodulation Market
Pain Management Devices Market
Interventional Oncology Market
Get access to the latest updates on Ablation Technology Companies and Ablation Technology Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original content:https://www.prnewswire.co.uk/news-releases/ablation-technology-market-worth-9-62-billion-by-2029-driven-by-emerging-tech-innovations–marketsandmarkets-302229348.html
Technology2 days ago
Technology5 days ago
Technology4 days ago
Technology5 days ago
Technology4 days ago
Technology4 days ago